A MAVRIC Reading List

Feel like yourself again. Start by measuring why you don't.

If you've stopped feeling strong, clear, and like yourself — that's not just age, and it's not in your head. It might be on a lab your doctor never ran. Inside: the five labs the standard physical skips, the 2023 trial that settled the cardiovascular safety question, and what a real testosterone protocol looks like in 2026.

Twelve pages. No pitch. Cited throughout.

Send the protocol.

PDF in your inbox in under five minutes. No autoresponder loop. No sales call unless you ask for one.

First name

State of residence

What brought you here? (optional, one line)

What's inside

Three reframes. One protocol. Real citations.

01 — The Reframe

GLP-1 is a longevity drug.

Cardiovascular. Renal. Inflammatory. Cognitive. The weight comes off as a side effect of what these molecules actually do. SELECT, FLOW, STEP-HFpEF, EVOKE — cited inline so you can read the papers.

02 — The Testosterone Layer

TRT in 2026 isn't the 1995 protocol.

TRAVERSE settled the central safety question. The modern protocol — dose, frequency, monitoring, the five labs most doctors don't run — looks very different than what your urologist learned in residency.

03 — The Access

What 503A actually means.

Patient-specific clinical individualization. Why compounded medications are not knockoffs. How a licensed prescriber and a state-licensed compounding pharmacy actually work together — and what to ask before you trust either one.

Disclosures

Not medical advice. The MAVRIC Longevity Protocol is an educational document and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed clinician about your individual health.

Compounded medications are not FDA-approved. Compounded drugs are prepared by state-licensed pharmacies under a patient-specific prescription. Compounded versions of FDA-approved drugs are not evaluated by FDA for safety, effectiveness, or quality.

Individual results vary. Treatment outcomes depend on the patient's individual clinical context, adherence, and underlying conditions.

State availability varies. MAVRIC telehealth services are available where MAVRIC's licensed clinicians practice. Eligibility is determined at intake on a state-by-state basis; therapies available in one state may not be available in another.

AI-generated content notice (per Texas SB 1188 / HB 149, applied nationwide). Portions of this communication may include AI-assisted content. Any final clinical decision is made by a licensed clinician based on patient-specific evaluation.